Agilent (A) Buy Rating Reconfirmed at Robert W. Baird; With $78.0 Target; Blackrock Health Sciences Trust Has 1.63 Sentiment

February 15, 2018 - By Clifton Ray

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The company has market cap of $298.70 million. The fund is managed by BlackRock Advisors, LLC. It has a 8.02 P/E ratio. It invests in the public equity markets of the United States.

Among 14 analysts covering Agilent Technologies (NYSE:A), 10 have Buy rating, 0 Sell and 4 Hold. Therefore 71% are positive. Agilent Technologies has $88 highest and $5 lowest target. $68.85’s average target is -4.57% below currents $72.15 stock price. Agilent Technologies had 54 analyst reports since August 14, 2015 according to SRatingsIntel. The firm has “Overweight” rating by Morgan Stanley given on Wednesday, March 15. The stock of Agilent Technologies, Inc. (NYSE:A) has “Buy” rating given on Tuesday, August 25 by TheStreet. The stock has “Outperform” rating by Leerink Swann on Thursday, November 10. The stock of Agilent Technologies, Inc. (NYSE:A) earned “Buy” rating by Evercore on Wednesday, January 3. Barclays Capital maintained it with “Buy” rating and $71.0 target in Tuesday, November 21 report. Robert W. Baird maintained it with “Buy” rating and $76.0 target in Thursday, January 18 report. Jefferies maintained Agilent Technologies, Inc. (NYSE:A) rating on Thursday, February 15. Jefferies has “Buy” rating and $81.0 target. Cowen & Co maintained it with “Outperform” rating and $51 target in Thursday, August 18 report. The stock of Agilent Technologies, Inc. (NYSE:A) earned “Overweight” rating by Morgan Stanley on Tuesday, November 14. As per Tuesday, September 26, the company rating was initiated by Goldman Sachs.

Since August 16, 2017, it had 0 insider purchases, and 10 insider sales for $14.15 million activity. $79,200 worth of stock was sold by HIRSCH DIDIER on Wednesday, September 13. Doak Mark had sold 15,567 shares worth $1.06 million. The insider Kaltenbach Patrick sold $316,300. $806,434 worth of Agilent Technologies, Inc. (NYSE:A) was sold by Grau Dominique. McMullen Michael R. sold $1.58 million worth of Agilent Technologies, Inc. (NYSE:A) on Thursday, January 18. $286,335 worth of Agilent Technologies, Inc. (NYSE:A) was sold by KOH BOON HWEE.

The stock increased 3.52% or $2.45 during the last trading session, reaching $72.15. About 2.63 million shares traded or 22.46% up from the average. Agilent Technologies, Inc. (NYSE:A) has risen 25.96% since February 15, 2017 and is uptrending. It has outperformed by 9.26% the S&P500.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company has market cap of $23.28 billion. The Company’s Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. It has a 34.36 P/E ratio. The companyÂ’s Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients.

Investors sentiment increased to 1.4 in Q3 2017. Its up 0.18, from 1.22 in 2017Q2. It improved, as 26 investors sold Agilent Technologies, Inc. shares while 166 reduced holdings. 74 funds opened positions while 194 raised stakes. 267.56 million shares or 0.84% less from 269.83 million shares in 2017Q2 were reported. Pub Employees Retirement Of Ohio stated it has 0.13% of its portfolio in Agilent Technologies, Inc. (NYSE:A). Cambridge Inv Advsr stated it has 0.01% of its portfolio in Agilent Technologies, Inc. (NYSE:A). Liberty Mutual Group Asset holds 0.05% or 13,412 shares. Old Mutual Global Investors (Uk) invested in 1,220 shares. Us Fincl Bank De invested 0.02% of its portfolio in Agilent Technologies, Inc. (NYSE:A). 214,311 are owned by Artemis Invest Mgmt Llp. Moreover, British Columbia Investment Mngmt Corporation has 0.16% invested in Agilent Technologies, Inc. (NYSE:A) for 331,920 shares. Echo Street Cap Mgmt Limited Co reported 110,558 shares. Tarbox Family Office owns 143 shares. Bnp Paribas Asset Management owns 76,024 shares for 0.04% of their portfolio. Comerica Incorporated holds 0.03% or 3,532 shares in its portfolio. Shine Investment Advisory Services owns 514 shares for 0.02% of their portfolio. Rhumbline Advisers accumulated 549,286 shares. Hightower Advsr Ltd Liability Corp holds 14,194 shares or 0.01% of its portfolio. Park Natl Oh accumulated 3,904 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: